For your skin
Fades stubborn dark patches like melasma and deep marks left behind by acne or hormonal shifts. The one to reach for when other brighteners haven't worked.
Want the science? Keep reading ↓Mechanism of action
Plasmin inhibitor that interrupts the UV-triggered melanogenesis pathway in keratinocytes.
Why we tier this strong
7 cited papers across 4 countries. Multiple positive efficacy results plus regulatory backing. Clears our published bar (Strong = 15+ studies with multiple randomized controlled trials (RCTs), or a single large longitudinal cohort).
Layering matrix
Read the research
Compare with
Cited research
Liang Y et al., Comparative efficacy and safety of tranexamic acid for melasma by different administration methods: A systematic review and network meta-analysis, Journal of Cosmetic Dermatology 2024 — oral TXA + topical agents most effective delivery route
Tranexamic Acid Ameliorates Skin Hyperpigmentation by Downregulating Endothelin-1 Expression in Dermal Microvascular Endothelial Cells, Annals of Dermatology 2024;36(3):151-162 — mechanism study showing oral TXA suppresses endothelin-1 in vascular endothelial cells
Feng X et al., Efficacy and safety of tranexamic acid in the treatment of adult melasma: An updated meta-analysis of randomized controlled trials, Journal of Clinical Pharmacy and Therapeutics 2021 — oral TXA is effective and safe for melasma, especially as adjuvant
MFDS Notified Functional Cosmetic Active — Tranexamic Acid (whitening). Korean Ministry of Food and Drug Safety, Cosmetic Functional Active Ingredient List — notified whitening active under the Korean Functional Cosmetics Codex; plasmin-inhibitor mechanism interrupts UV-triggered melanogenesis
Tranexamic Acid Diminishes Laser-Induced Melanogenesis, Annals of Dermatology 2015;27(3):250-256 — TXA reduces melanin production and tyrosinase activity in melanocytes; candidate for post-inflammatory hyperpigmentation
Na JI et al., Effect of tranexamic acid on melasma: a clinical trial with histological evaluation, Journal of the European Academy of Dermatology and Venereology 2013 — topical TXA reduced melasma severity with corresponding histological pigment reduction
Maeda K, Naganuma M, Topical trans-4-aminomethylcyclohexanecarboxylic acid prevents ultraviolet radiation-induced pigmentation, Journal of Photochemistry and Photobiology B 1998;47(2-3):136-41
Sources: PubMed · KCI · J-Stage · CNKI · Wanfang · SFD · MFDS · Cochrane · SCCS · CIR. Every entry points to a specific document. See methodology for what each outcome label means.